Results 101 to 110 of about 7,672 (251)
Acute and non‐acute decompensation of liver cirrhosis (47/130)
Liver International, Volume 45, Issue 3, March 2025.Abstract In the traditional view, the occurrence of cirrhosis‐related complications, such as hepatic encephalopathy, formation of ascites or variceal haemorrhage, marks the transition to the decompensated stage of cirrhosis. Although the dichotomous stratification into a compensated and decompensated state reflects a prognostic water‐shed moment and ...
Martin S. Schulz +2 more
wiley +1 more source
Terlipressin for acute esophageal variceal hemorrhage
Cochrane Database of Systematic Reviews, 2003 Terlipressin (triglycyl lysine vasopressin) is a synthetic analogue of vasopressin, which has been used in the treatment of acute variceal hemorrhage. In contrast to vasopressin, terlipressin can be administered as intermittent injections instead of continuous intravenous infusion and it has a safer adverse reactions profile. However, its effectiveness
Ioannou, G., Doust, J., Rockey, D. C.
openaire +5 more sources
Terlipressin for septic shock patients: a meta-analysis of randomized controlled study
Journal of Intensive Care, 2019 Background Catecholamines are commonly used in septic shock but face limitations of their hypo-responsiveness and adverse events due to high dose. Terlipressin is a synthetic vasopressin analog with greater selectivity for the V1-receptor.
Yibing Zhu +3 more
doaj +1 more source
Fármacos que atuam modulando a ação da vasopressina [PDF]
, 2015 Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Ciências FarmacêuticasA vasopressina, também é designada por hormona antidiurética (ADH), a nível renal aumenta a
Cardoso, Ana Catarina Santos
core
Contemporary Clinical Trials Communications, 2023 Background: Hepatorenal syndrome-acute kidney injury (HRS-AKI) carries significant morbidity and mortality among those with end-stage liver disease. Bolus terlipressin for treatment of HRS-AKI received FDA approval in September 2022. US implementation of
Ethan Weinberg +14 more
doaj
JHEP Reports, 2019 Background & Aims: Portal hypertension contributes to the pathogenesis of malnutrition and sarcopenia in cirrhosis via multiple mechanisms. Terlipressin is a vasopressin analogue that we administer via continuous outpatient infusion, as a bridge to ...
Brooke Chapman +8 more
doaj
Clinical implications of the hyperdynamic syndrome in cirrhosis. [PDF]
, 2014 The hyperdynamic syndrome is a late consequence of portal hypertension in cirrhosis. The principal hemodynamic manifestations of the hyperdynamic syndrome are high cardiac output, and increased heart rate and total blood volume, accompanied by reduced ...
CALVARUSO, Vincenza +5 more
core +1 more source
Terlipressin-induced skin necrosis [PDF]
BMJ Case Reports, 2021 Gaurav Jain +3 more
openaire +3 more sources
Self-expandable metal stents in the treatment of acute esophageal variceal bleeding [PDF]
, 2014 Acute variceal bleeding (AVB) is a life-threatening complication in patients with cirrhosis. Hemostatic therapy of AVB includes early administration of vasoactive drugs that should be combined with endoscopic therapy, preferably banding ligation. However,
Bosch i Genover, Jaume +1 more
core +2 more sources
Endoscopic treatment of bleeding gastric varices with histoacryl (N-butyl-2-cyanoacrylate): a South European single center experience [PDF]
, 2012 BACKGROUND: Endoscopic injection of N-butyl-2-cyanoacrylate is the current recommended treatment for gastric variceal bleeding. Despite the extensive worldwide use, there are still differences related to the technique, safety, and long term-results.
Almeida, N +9 more
core +1 more source